Tower Research Capital LLC (TRC) - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 26 filers reported holding TENAX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1
-100.0%
9,526
-3.5%
0.00%
Q3 2022$2,000
-33.3%
9,873
+2.5%
0.00%
Q2 2022$3,000
-25.0%
9,628
+99.7%
0.00%
Q1 2022$4,000
-20.0%
4,822
+1.6%
0.00%
Q4 2021$5,0004,745
+47350.0%
0.00%
Q3 2021$0
-100.0%
10
-99.2%
0.00%
Q2 2021$3,000
+200.0%
1,231
+95.1%
0.00%
Q1 2021$1,000
-97.0%
631
-96.4%
0.00%
-100.0%
Q4 2020$33,000
+312.5%
17,716
+235.0%
0.00%
Q3 2020$8,0005,2890.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 43,164$61,0000.02%
FAS Wealth Partners, Inc. 58,576$83,0000.01%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 12,200$17,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,018$7,0000.00%
UBS Group AG 72$00.00%
IFP Advisors, Inc 0$00.00%
Advisor Group, Inc. 3,065$4,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders